Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China · Delayed Price · Currency is CNY 26.45
+0.05 (0.19%)
May 20, 2026, 2:02 PM CST
SHA:688566 Revenue
Jiangsu Jibeier Pharmaceutical had revenue of 226.42M CNY in the quarter ending March 31, 2026, with 12.20% growth. This brings the company's revenue in the last twelve months to 990.68M, up 9.58% year-over-year. In the year 2025, Jiangsu Jibeier Pharmaceutical had annual revenue of 966.07M with 7.76% growth.
Revenue (ttm)
990.68M
Revenue Growth
+9.58%
P/S Ratio
5.31
Revenue / Employee
746.56K
Employees
1,326
Market Cap
5.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 966.07M | 69.53M | 7.76% |
| Dec 31, 2024 | 896.53M | 35.60M | 4.14% |
| Dec 31, 2023 | 860.93M | 206.20M | 31.49% |
| Dec 31, 2022 | 654.73M | 145.04M | 28.46% |
| Dec 31, 2021 | 509.69M | -56.28M | -9.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsJiangsu Jibeier Pharmaceutical News
- 22 days ago - Jiangsu Jibeier Pharmaceutical Annual report: Q4 2025 - Filings
- 22 days ago - Jiangsu Jibeier Pharmaceutical Quarterly report: Q1 2026 - Filings
- 7 months ago - Jiangsu Jibeier Pharmaceutical Quarterly report: Q3 2025 - Filings
- 9 months ago - Jiangsu Jibeier Pharmaceutical Quarterly report: Q2 2025 - Filings